Adaani E. Frost
Baylor College of Medicine
6620 Main St
Ste 1225
Houston
USA
Name/email consistency: high
- The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries. Frost, A.E., Badesch, D.B., Barst, R.J., Benza, R.L., Elliott, C.G., Farber, H.W., Krichman, A., Liou, T.G., Raskob, G.E., Wason, P., Feldkircher, K., Turner, M., McGoon, M.D. Chest (2011)
- Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol. Frost, A.E., Quiñones, M.A., Zoghbi, W.A., Noon, G.P. J. Heart Lung Transplant. (2005)
- The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: demonstration of a ceiling effect. Frost, A.E., Langleben, D., Oudiz, R., Hill, N., Horn, E., McLaughlin, V., Robbins, I.M., Shapiro, S., Tapson, V.F., Zwicke, D., DeMarco, T., Schilz, R., Rubenfire, M., Barst, R.J. Vascul. Pharmacol. (2005)









